Episode Details

In episode 20 of Health:Further, we'll be covering some interesting topics, including:

• Walgreens teaming up with Pearl Health, a primary care enablement tech company, to expand its efforts in value-based care.
• The steep rise in health insurance costs, with experts predicting the biggest increase in over a decade, which could have a major impact on businesses and their employees in 2024.
• An advisory panel to the FDA unanimously agreed that a common decongestant ingredient found in many over-the-counter cold medicines is actually ineffective. This could potentially lead to a ban on the ingredient phenylephrine and the removal of hundreds of products from store shelves.

And many more! Please check out our Episode Resources below:


------🔎RESOURCES🔎


CPI Report for August (BLS)

An Important Shift in Fed Officials’ Rate Stance Is Under Way (WSJ)

Walgreens inks deal with Pearl Health on value-based care (Modern Healthcare)

Health-Insurance Costs Are Taking Biggest Jumps in Years (WSJ)

Generic Drugs Should Be Cheap, but PBMs Are Charging Thousands (WSJ)

Cost Plus Drugs

People Rely on Laxatives So Much, There Aren’t Enough to Go Around (WSJ)

A Decongestant in Cold Medicines Doesn’t Work at All, an F.D.A. Panel Says (NYT)

Columbia Ignored Women, Undermined Prosecutors and Protected a Predator for over 20 Years (ProPublica)

See No Evil, Hear No Evil, Speak No Evil (Esquire)



------🔔SIGN UP FOR EPISODE NOTIFICAT

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK